Episodes

Yasmin Karimi, MD Diffuse large B-cell lymphoma is the most common subtype of non-Hodgkin lymphoma. Tune in as we chat with Dr. Yasmin Karimi from the University of Michigan about the latest breakthroughs in treatment, including combination therapies, CAR T-cell therapy and bispecific antibodies. Discover how these innovations are offering new hope and pathways to cures for patients. DOWNLOAD TRANSCRIPT CLICK HERE to participate in our episode survey. Mentioned on this episode: Diffuse large...

Rashad Hayes, LMSW Join us for a powerful message of hope and perseverance after a cancer diagnosis. In this episode, Rashad Hayes shares his experience of being diagnosed with follicular lymphoma at 22 years old and how it motivated him to reevaluate his mindset and push forward. Now a social worker and motivational speaker, Rashad introduces his C.A.K.E. methodology, a unique approach to embracing life’s challenges. Don’t miss out on this uplifting episode of resilience and adaptation in the...

Sara Grisales Jaramillo, LMSW Navigating the maze of cancer care can be overwhelming. Join us as Sara Grisales Jaramillo, LMSW, of CancerCare® discusses the challenges patients face in accessing affordable treatment and strategies to improve cancer outcomes. DOWNLOAD TRANSCRIPT CLICK HERE to participate in our episode survey. Mentioned on this episode: CancerCare Navajo Nation: The First Cancer Center on a Reservation podcast episode Cafecito con LLS: Hablemos de los Ensayos Clínicos (Coff...

Ambreen Maan, MSW, LSW Megan Gilman, MD Peter Drahms, RN, BSN, C. Robert Bennett, PhD, CPNP-AC Please join us for this special episode live from CancerCon®, a young adult cancer conference presented by Stupid Cancer®. A diagnosis of cancer can present many challenges when it comes to relationships with others and the relationship you have with yourself. In this episode, we speak with experts about rediscovering yourself after cancer, exploring mental health treatment, and cancer “ghosting”. ...

Brian Connell There are new Medicare changes starting in January 2025 that will benefit cancer patients. LLS Vice President of Federal Affairs, Brian Connell, joins us again on The Bloodline to inform us about these new changes and how they will impact Medicare patients. In this episode, you will learn about the key changes for Part D, the prescription drug plan for Medicare, as well as the drug plan for Medicare Advantage. One of these new changes requires action on the part of the Medicare e...

Please join us for this special episode live from CancerCon®, a young adult cancer conference presented by Stupid Cancer®. Following a cancer diagnosis and treatment, oncologists often become the default primary care for patients. Transitioning away from the oncologist to a primary care provider for general healthcare may be challenging at times for patients but may have tremendous benefits. In this episode, we ask young adults with cancer about their experiences transitioning to primary care d...

Mayur Narkhede, MD Living with chronic lymphocytic leukemia (CLL) can be a challenging journey for both patients and caregivers. However, there is a beacon of hope. Tune in to our latest episode, where we speak to Dr. Mayur Narkhede of the University of Alabama about groundbreaking research and innovative treatments for CLL. Discover the potential of CAR T-cell therapy, bispecific antibodies and other cutting-edge options that bring the promise of new hope and possibilities for those affected ...

Chronic myelomonocytic leukemia (CMML) has been a challenging disease to tackle, historically treated with therapies meant for other conditions. But there’s a new wave of hope! Join us as Dr. Eric Padron of Moffitt Cancer Center and Dr. Lee Greenberger of The Leukemia & Lymphoma Society unveil the groundbreaking new CMML Initiative, fueled by recent funding aimed at revolutionizing treatment. Discover how this initiative is paving the way for individualized therapies that promise to enhance the...

David Bond, MD The treatment landscape for non-Hodgkin lymphoma has significantly evolved over the past few decades. With groundbreaking advancements in CAR T-cell therapy and bispecific antibodies, researchers are making strides toward curative treatments and enhancing patients’ quality of life. In this episode, we speak with Dr. David Bond from The Ohio State University about the latest developments in treating both aggressive and slow-growing non-Hodgkin lymphomas. He discusses innovative, ...

Shernan Holtan, MD Paul Rothweiler Joe Grey Exercise, or simply moving the body, can be an important part of cancer recovery, both physically and emotionally. In this episode, Dr. Shernan Holtan of Roswell Park Comprehensive Cancer Center and blood cancer survivors, Paul Rothweiler and Joe Grey, share about a clinical trial they developed to introduce a personalized strength training program to patients and caregivers. Dr. Holtan highlights the benefits of strength training for all patients, ...

Alissa Huston, MD Julie Larson, LCSW Shirley D’Sa, MD, FRCP, FRCPath For patients with chronic blood cancers, such as Waldenström Macroglobulinemia (WM), quality of life is a main priority. Physical and emotional side effects of the disease or treatment may present several challenges for patients and caregivers. In this episode, we were onsite at the International Waldenström‘s Macroglobulinemia Foundation’s 2024 IWMF Educational Forum in Renton, WA. Elissa met with experts who discussed how ...

Marco Davila, MD Explore the cutting-edge of oncology as we delve into the revolutionary world of CAR T-cell therapy, a more recent medical advancement in the fight against blood cancer. Join our conversation with Dr. Marco Davila of Roswell Park Comprehensive Cancer Center in Buffalo, NY, as he highlights the significant impact CAR T-cell therapy has made on treating various blood cancers. Dr. Davila discusses the current uses of this therapy and gives us a look at the ongoing clinical trials...

In this episode, we speak with Dr. Matthew Matasar of Rutgers Cancer Institute, and Elizabeth Stone, who was diagnosed with Hodgkin lymphoma in 2012. Dr. Matasar discusses the current and emerging treatments for Hodgkin lymphoma. Elizabeth shares her story of resilience as a refractory patient throughout multiple treatments, and how she has navigated a life of hardships, joy, love and friendship while in a highly immunocompromised state. DOWNLOAD TRANSCRIPT CLICK HERE to participate in our epi...

Ricardo Lopez, Dietista Oncológico MSHA, RD, CSO, LDN Unase a nosotros en nuestra conversación con Ricardo Lopez, Dietista Oncológico. En este episodio él nos explicará la importancia de tener una nutrición adecuada antes, durante y después de un tratamiento, y nos proveerá consejos para aliviar efectos secundarios causado por el cáncer. DESCARGAR TRANSCRIPCIÓN HAGA CLIC AQUI para participar en la encuesta del episodio. Mencionado en este episodio: La American Heart Association (AHA) Temas ...

Ashlie D’Andrea Emma D’Andrea Lynn Steele, LSW, OSW-C In this episode, we speak to a myeloma patient and her teenage daughter about the impact that myeloma had on her family. Lynn Steele, a social worker and Information Specialist at LLS, then joins us to share tips and resources on how families can navigate a cancer diagnosis together. DOWNLOAD TRANSCRIPT CLICK HERE to participate in our episode survey. Mentioned on this episode: Multiple myeloma Talking to children and families about canc...

Sharon Castellino, MD, MSc In this episode, Dr. Sharon Castellino, a pediatric oncologist at Children’s Healthcare of Atlanta, examines the impact of healthcare equity and barriers to care for patients and caregivers dealing with blood cancer. Dr. Castellino sheds light on how groundbreaking treatments have transformed the landscape of cancer care, emphasizing the crucial role that LLS, patient advocates and government entities can play in ensuring accessible and quality care for all. DOWNLOA...

Teresa Altemeyer Join us on a heartfelt journey woven by support and education, as we speak to Teresa Altemeyer, who was diagnosed with chronic lymphocytic leukemia in 2009. In this episode, Teresa shares her experience with CLL from diagnosis through long-term survivorship. On the advice of her doctor, she went out to live her life, and found herself supporting other blood cancer patients and survivors in doing the same. Despite her own physical and mental health struggles with this disease, s...

Elie Traer, MD Karin Rodland, PhD Lee Greenberger, PhD The fight to effectively treat and cure the complex disease of acute myeloid leukemia (AML) continues. In this episode, we speak to Dr. Elie Traer, Dr. Karin Rodland and Dr. Lee Greenberger about an exciting new study for AML. The doctors share about a longtime collaboration between Oregon Health & Science University (OHSU) and Pacific Northwest National Laboratory (PNNL) using patient samples from LLS’s Beat AML Master Clinical Trial to ...

Monica Fawzy Bryant, Esq. Dealing with cancer extends beyond physical health, often bringing financial challenges that can overwhelm patients and their loved ones. In this episode, we offer a beacon of support as we speak to Monica Bryant, Esq., a cancer rights attorney and Co-founder/Chief Operating Officer of Triage Cancer. She reviews the financial hurdles that may arise during treatment and provides practical strategies to help with economic hardships. She also highlights a wealth of resou...

Mayra Gomez Padua, PhD Ser cuidador, para muchos es una muestra de compasión. Sin embargo, a medida que pasa el tiempo, muchos cuidadores se encuentran abrumados por el estrés, la carga, y la tristesa asociado con ser un cuidador de alguien dianosticado con cáncer. En muchas ocaciones los cuidadores se encuentran dejando su salud al lado. En este episodio, la Dra. Mayra Gómez Padua, psicóloga clínica bilingüe nos explica la importancia de mantener el equilibrio entre ser cuidador y manteniendo...

Naveen Pemmaraju, MD “If you have a rare disease, it’s not rare to you.” In this episode, Dr. Naveen Pemmaraju of MD Anderson Cancer Center in Houston, TX, sheds light on the latest treatment advancements for myelofibrosis. The pace of scientific discovery for rare diseases is moving at a fast rate, resulting in better outcomes for myelofibrosis patients. *This episode was recorded on Rare Disease Day, February 29, 2024 DOWNLOAD TRANSCRIPT CLICK HERE to participate in our episode survey. Men...

Nishi Shah, MD, MBBS Remarkable progress has been made in the treatment of myeloma over the past decade, giving patients and families much hope for the future. In this episode, we speak to Dr. Nishi Shah of Montefiore Einstein Comprehensive Cancer Center in New York City. While the wide variety of therapies available to patients are discussed, this episode also focuses on the newest, cutting-edge therapies for myeloma, such as CAR T-cell therapy and bispecific antibodies. DOWNLOAD TRANSCRIPT C...

In the episode, we explore the family of diseases called myeloproliferative neoplasms (MPNs). Dr. Anand Patel and Dr. Olatoyosi Odenike of The University of Chicago Medicine share the latest advances in treatments for MPNs, including myelofibrosis (MF), polycythemia vera (PV) and essential thrombocythemia (ET). We also highlight how treatment teams prioritize the improvement of patients’ quality of life as a key aspect of care. DOWNLOAD TRANSCRIPT CLICK HERE to participate in our episode survey...

Nutrition is a crucial part of cancer care. Many patients and caregivers play an active role in managing their nutrition during and after treatment. In this episode, we discuss nutrition after a cancer diagnosis with Luz Chavez and Susanne Massarani, Registered Dietitians from The University of Chicago. Learn the basics of oncology nutrition and how a good diet can help combat treatment-related weight loss and side effects. Caregivers will also benefit from tips on how to care for their loved on...